InnovAge appoints Michael Scarbrough as President and COO; separates CEO and President roles

InnovAge Holding Corp.

Michael Scarbrough appointed President and COO effective Nov 4, 2024; Christine Bent steps down as COO and becomes Senior Advisor through Dec 31.
Scarbrough receives $485k base salary, 75% target bonus, and 1M Class B Units (50% time-vested over 4 years, 50% performance-vested tied to Apax MOIC thresholds).
Patrick Blair ceases as President but remains CEO; roles separated to improve strategic execution.
Maria Lozzano promoted to President, Pharmacy Services, reporting to CEO.
Bent receives $100k cash separation, 6 months COBRA, and 28,860 RSUs vesting June 2025; 57,721 RSUs forfeited.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Michael Scarbrough

President and Chief Operating Officer

INNV · InnovAge Holding Corp.

Effective: 2024-11-04
Filed: November 4, 2024, 6:59 PM ET

appointed Michael Scarbrough as President and Chief Operating Officer of the Company, effective as of November 4, 2024

Departed

Christine Bent

Chief Operating Officer

INNV · InnovAge Holding Corp.

Effective: 2024-11-04
Successor: Michael Scarbrough
Filed: November 4, 2024, 6:59 PM ET

Christine Bent, who departed from the role of the Company’s Chief Operating Officer on October 31, effective as of the Transition Date

Role change

Patrick Blair

Chief Executive Officer

INNV · InnovAge Holding Corp.

Effective: 2024-11-04
Successor: Michael Scarbrough
Filed: November 4, 2024, 6:59 PM ET

Mr. Patrick Blair, the Company’s President and Chief Executive Officer, will cease to serve as the President of the Company and will continue serving as the Company’s Chief Executive Officer

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Scarbrough was appointed as President and Chief Operating Officer at InnovAge Holding Corp..

Action: appointed
Role: President and Chief Operating Officer

Exact text from the filing

appointed Michael Scarbrough as President and Chief Operating Officer of the Company, effective as of November 4, 2024

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Christine Bent departed as Chief Operating Officer at InnovAge Holding Corp..

Action: departed
Role: Chief Operating Officer

Exact text from the filing

Christine Bent, who departed from the role of the Company’s Chief Operating Officer on October 31, effective as of the Transition Date

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Patrick Blair changed role as Chief Executive Officer at InnovAge Holding Corp..

Action: ceased to serve as President
Role: Chief Executive Officer

Exact text from the filing

Mr. Patrick Blair, the Company’s President and Chief Executive Officer, will cease to serve as the President of the Company and will continue serving as the Company’s Chief Executive Officer

View on SEC.gov

InnovAge Holding Corp. filing history →

Source: SEC EDGAR

accession 0001834376-24-000080

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.